Boston scientific received information that a patient implanted with a st jude medical lead, exhibited undersensing, loss of capture (loc) and right ventricular (rv) threshold issues.The lead impedance measurements were stable, and there were no adverse patient effects reported other than the patient complaining of intermittent chest pain.The decision was made to reprogram the device.It should be noted the associated rv lead is a competitor product.Hospital: royal alexandra hospital canada event date (b)(6) 2011.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|